| Breakdown | TTM | Apr 2026 | Apr 2025 | Apr 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.14B | 36.34B | 36.10B | 37.05B | 37.64B | 38.00B |
| Gross Profit | 19.52B | 19.50B | 19.58B | 20.00B | 20.12B | 19.75B |
| EBITDA | 2.12B | 1.84B | 2.13B | 2.74B | 3.49B | 3.29B |
| Net Income | 705.00M | 700.00M | 701.00M | 1.40B | 1.89B | 1.70B |
Balance Sheet | ||||||
| Total Assets | 18.25B | 18.26B | 19.38B | 21.88B | 21.86B | 20.13B |
| Cash, Cash Equivalents and Short-Term Investments | 6.93B | 7.11B | 8.00B | 10.71B | 11.35B | 10.55B |
| Total Debt | 94.00M | 91.00M | 52.00M | 46.00M | 7.00M | 13.00M |
| Total Liabilities | 3.87B | 3.81B | 4.34B | 4.22B | 4.85B | 4.29B |
| Stockholders Equity | 14.38B | 14.45B | 15.04B | 17.66B | 17.01B | 15.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.08B | 751.00M | 383.00M | 1.91B | 3.53B |
| Operating Cash Flow | 0.00 | 1.54B | 1.75B | 1.41B | 2.55B | 3.74B |
| Investing Cash Flow | 0.00 | -657.00M | -2.95B | -1.15B | -699.00M | -418.00M |
| Financing Cash Flow | 0.00 | -826.00M | -905.00M | -895.00M | -1.05B | -789.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥52.21B | 11.43 | ― | 0.52% | -1.79% | 27.43% | |
60 Neutral | ¥13.58B | 4.67 | ― | 3.17% | 5.80% | 1.52% | |
59 Neutral | ¥26.02B | 28.72 | ― | 3.23% | -0.09% | 17.71% | |
58 Neutral | ¥11.97B | 10.12 | ― | 4.65% | 3.96% | 116.45% | |
57 Neutral | ¥117.84B | 25.21 | ― | 3.02% | 3.76% | -35.18% |